Location: Home
  • search
  • go
  • Relate News
  • 11/17/2017CFDA Solicits Comments on Draft Amendment to the Rules for CFDA Legisl...
  • 11/16/2017Recent Official and Executive Moves
  • 11/16/2017Shanghai Pharma Eyes Acquisitions in the U.S. and Europe Following Car...
  • 11/16/2017CIRC Releases Draft Amendment of Health Insurance Regulation
  • 11/15/2017Fujian-led Inter-provincial Drug Purchase Alliance Imminent
  • 11/15/2017Ascentage Announces U.S. FDA Acceptance of Its IND for Novel IAP Inhib...
  • 11/15/2017Update on Antitrust Legislative Development in China
  • 11/15/2017Competition Impact Review to Be Required for All New Chinese Regulatio...
  • 11/15/2017China Issues New Measure to Ensure Fair Competition
  • 11/15/2017Is Walgreens Boots Alliance Pulling Out of Chinese JV Guangzhou Pharma
  • 11/14/2017Ongoing Healthcare Reform in China
  • 11/14/2017Reckitt Benckiser, Alibaba Join Hands to Market Quality Health Product...
  • 11/14/2017U.S. Employs Rarely Used Tool to Probe China IP Practices
  • 11/14/2017Shanghai Pharma Buys Cardinal Health's China Business for $1.2B
  • 11/14/2017CFDA Solicits Public Comments on Provisions for Regulation of Internet...
  • 11/13/2017McKinsey: Chinese Healthcare Market to Reach $1 Trillion by 2020
  • 11/13/2017Guo Guangchang to Resign Executive Posts at All Fosun Subsidiaries
  • 11/13/2017RiboQuark Enrolls First Patient in China for a Global Pivotal Trial fo...
  • 11/13/2017The National Cancer Center Joins Hands with WHO on the Fight against C...
  • 11/13/2017XiAn Janssen Launches IMBRUVICA (ibrutinib) in China
  • 11/13/2017CFDA Issues New Announcement to Adjust Drug Registration Acceptance Ru...
  • 11/13/2017CDE Seeks Comments on First List of Essential Drugs Eligible for BE Ex...
  • 11/13/2017Pfizer Divests from Chinese JV with Hisun
  • 11/10/2017Time for MNCs to Stay Sober as China Unleashes Enticing Drug Regulator...
  • 11/9/2017AstraZeneca Bets on Continued Growth in China as GSK Fades
  • 11/9/2017Recent Executive Moves
  • 11/9/2017SMEI: Chinese Drug Sales Growth Expected to Fall Further in 2017
  • 11/8/2017BeiGene Completes Construction of Its Manufacturing Facility in Suzhou
  • 11/8/2017Tsumura to Penetrate China's Herbal Drug Market with the Help of Ping ...
  • 11/8/2017Biotest and Tiancheng Pharma to Rework Their Acquisition Deal after Na...
  • Page:359/789 Total number of articles:23668: [First][<<] [357] [358] [359] [360] [361] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group